Retraction

Role of Nrf2 Signaling Pathway in the Radiation Tolerance of Patients with Head and Neck Squamous Cell Carcinoma: An in vivo and in vitro Study

Paper Information

Record ID:
38504
Publication Date:
March 23, 2017
Retraction Date:
July 28, 2022 (3.3 years years ago)
Article Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Retraction Details

Citations (23)

23
Total Citations
3
Post-Retraction
(13.0%)
20
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
567 Days since retraction (latest)
ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas
Vinh Nguyen, Travis P. Schrank, Michael B. Major et al. (4 authors)
PLoS ONE Open Access
Published: Feb 2024
1 citation
567 days after retraction
Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment
Jing Yang, Zhaowei Gu
Frontiers in Pharmacology Open Access
Published: Jan 2024
5 citations
540 days after retraction
<i>Amomum subulatum</i> mitigates experimental thoracic radiation-induced lung injury by regulating antioxidant status and inflammatory responses
Sudarsanan Drishya, Suresh Sulekha Dhanisha, Paramu Raghukumar et al. (4 authors)
Food & Function
Published: Jan 2023
10 citations
157 days after retraction
A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
Chang Jiang, Nathan P. Ward, Nicolas Prieto-Farigua et al. (7 authors)
Redox Biology Open Access
Published: Jun 2022
12 citations
56 days before retraction
A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
Chang Jiang, Nathan P. Ward, Nicolas Prieto-Farigua et al. (7 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Mar 2022
142 days before retraction
HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells
Chenxing Da, Jun Pu, Zhe Liu et al. (10 authors)
Signal Transduction and Targeted Therapy Open Access
Published: Nov 2021
24 citations
246 days before retraction
NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch
Séan M. O’Cathail, Chieh‐Hsi Wu, Rachael J. Thomas et al. (6 authors)
Antioxidants Open Access
Published: Aug 2021
16 citations
334 days before retraction
<scp>HO</scp>‐1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy
Ryujiro Akaishi, Fumiyoshi Fujishima, Hirotaka Ishida et al. (16 authors)
Cancer Reports Open Access
Published: Jul 2021
6 citations
378 days before retraction
Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
Emiliano Panieri, Luciano Saso
Antioxidants and Redox Signaling
Published: Jan 2021
32 citations
568 days before retraction
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
Ya-Chu Tang, Jenn-Ren Hsiao, Shih-Sheng Jiang et al. (15 authors)
Theranostics Open Access
Published: Jan 2021
87 citations
573 days before retraction
The transcription factor NRF2 shapes the identity of radio-resistant tumor cells
Gina Manda, Antonio Cuadrado
Journal of Cell Identity Open Access
Published: Nov 2020
623 days before retraction
Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models
Katherine Deland, Bryce Starr, Joshua S. Mercer et al. (11 authors)
Journal of Clinical Investigation Open Access
Published: Sep 2020
35 citations
667 days before retraction
Tumor genotype dictates radiosensitization after<i>Atm</i>deletion in brainstem gliomas
Katherine Deland, Bryce Starr, Joshua S. Mercer et al. (11 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Aug 2020
1 citation
703 days before retraction
Radiosensitization by Kinase Inhibition Revealed by Phosphoproteomic Analysis of Pancreatic Cancer Cells
Svenja Wiechmann, Elena Saupp, Daniela Schilling et al. (9 authors)
Molecular & Cellular Proteomics Open Access
Published: Jul 2020
14 citations
747 days before retraction
Inhibition of Nrf2 might enhance the anti-tumor effect of temozolomide in glioma cells via inhibition of Ras/Raf/MEK signaling pathway
Wei Sun, Weihua Zhang, Jianyong Yu et al. (5 authors)
International Journal of Neuroscience
Published: May 2020
18 citations
812 days before retraction
Drug Repurposing Patent Applications July–September 2019
Hermann AM Mucke
Assay and Drug Development Technologies
Published: Feb 2020
1 citation
903 days before retraction
Impact and Relevance of the Unfolded Protein Response in HNSCC
Olivier Pluquet, Antoine Galmiche
International Journal of Molecular Sciences Open Access
Published: May 2019
12 citations
1155 days before retraction
Potential Applications of NRF2 Inhibitors in Cancer Therapy
Emiliano Panieri, Luciano Saso
Oxidative Medicine and Cellular Longevity Open Access
Published: Apr 2019
163 citations
1204 days before retraction
Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma
Alfredo Cruz‐Gregorio, Imelda Martínez-Ramírez, José Pedraza‐Chaverrí et al. (4 authors)
Cancers Open Access
Published: Feb 2019
45 citations
1269 days before retraction
Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells
Kanako Ono, Ayako Furugen, Yuko Kurosawa et al. (7 authors)
Placenta Open Access
Published: Nov 2018
12 citations
1339 days before retraction
Deleted Work
Unknown Authors
Unknown Journal
Published: Nov 1955
24372 days before retraction
Quick Stats
Total Citations: 23
Years Since Retraction: 3.3 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers